HTGF
HTGF is a VC fund. It joined 1 round tracked by OSH in the last 90 days.
What they look for
Not published yet. OSH fills this in from HTGF's own site, or from its deals once OSH tracks them.
Activity
Deals, 90 days
1
Deals, 12 months
1
Led, 12 months
0
Median disclosed round
$35.3M
Frequent co-investors:Mérieux Equity PartnersNRW.BANKBoehringer Ingelheim Venture FundLilly VenturesAnobis Asset
Portfolio from OSH Rounds
| Date | Company | Amount | Stage | Lead | Other investors | Sector | Sources |
|---|---|---|---|---|---|---|---|
| €31.5M | Seed | Mérieux Equity Partners, NRW.BANK, Boehringer Ingelheim Venture Fund | Lilly Ventures +2 | — | 3 |
Nov 10 · Seed
SRTD Biotech€31.5MLed by Mérieux Equity Partners, NRW.BANK, Boehringer Ingelheim Venture Fund · with Lilly Ventures, +2
Questions and answers
How active is HTGF?
In OSH Rounds, HTGF joined 1 round in the last 90 days and 1 in the last 12 months, leading 0.
Sources
- 1.Why Lilly and Boehringer backed a German startup’s mRNA ‘on-off switch’ in a €31.5M seed — TFN — techfundingnews.com
- 2.mRNA therapy company SRTD Biotech has complet... — chaincatcher.com
- 3.SRTD Biotech Raises €31.5M in Seed Funding — finsmes.com